Skip to content

Palliative Radiation Oncology Chief's Clinic

Palliative Radiation Oncology Chief's Clinic (PROCC): Assessing the Impact of a Dedicated Clinic on the Timeliness of Palliative Radiotherapy

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03995927
Acronym
PROCC
Enrollment
15
Registered
2019-06-24
Start date
2019-07-15
Completion date
2020-04-05
Last updated
2023-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Disease, Metastasis

Keywords

Difficult to treat cancers

Brief summary

The proposed study represents a quality improvement study of a recently-developed dedicated radiation oncology subspecialty clinic with the goal of improving timeliness of palliative radiation therapy and improving resident training in palliative care topics. The aim of this study is to evaluate the impact of this clinic on time to palliative radiation therapy following referral.

Detailed description

Primary Objective: • Determine whether interval between palliative radiation therapy referral and palliative radiation therapy initiation is shorter for participants treated in a dedicated palliative radiation oncology clinic compared to the same interval for participants treated in a general radiation oncology clinic (historical control). The investigators' hypothesis is that this interval will be significantly shorter among the Palliative Radiation Oncology Chief's Clinic participants compared to historical control. Secondary Objectives: * Determine whether each of the three component intervals within the overall interval from referral to treatment initiation (i.e., referral to consultation; consultation to simulation; simulation to treatment) is shorter for participants treated in a dedicated palliative radiation oncology clinic compared to the length of the same intervals for participants treated in a general radiation oncology clinic (historical control). The investigators' hypothesis is that each of these component intervals will be significantly shorter among the Palliative Radiation Oncology Chief's Clinic participants compared to historical control. * Describe levels of and changes over time in patient-reported quality of life after palliative radiation therapy in the full sample, and in subgroups stratified by various radiation regimens. The investigators' hypothesis is that participants who receive a shorter course of palliative radiation (one day or five days) will have greater improvements in overall quality of life than participants who receive a ten-day course of palliative radiation. * Determine median overall survival after palliative radiation therapy.

Interventions

Only radiation oncology patients data from medical records regarding treatment, demographics and follow-up visits will be collected and logged by investigators.

OTHERQuality of Life Questionnaire

Participants will be asked to complete a set of short forms at first visit and post-treatment visits. If participant has a routine visit about 3 months after treatment, participant will be asked to complete a final form that is optional.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Clinically or pathologically-defined malignant disease amenable to palliative radiotherapy.

Exclusion criteria

* Pregnancy. A verbal pregnancy denial will suffice. * No intention to treat with palliative radiation therapy following initial referral and consult.

Design outcomes

Primary

MeasureTime frameDescription
Number of Days Between Referral and Start of Treatment3 monthsNumber of days between referral to palliative radiation therapy interval and start of palliative radiation therapy compared to historical control. Mean time from referral to the start of RT (measured in days) will be computed for our sample and compared to the historical control mean of 13.4 days using a two-sided one-sample t-test.

Secondary

MeasureTime frameDescription
Mean Time from Referral for Consultation3 monthsMean time from referral to consultation will be computed for our sample and compared to the historical control mean of 3.6 days.
Mean Time from Consultation to CT Simulation3 monthsMean time from consultation to CT simulation will be computed for our sample and compared to the historical control mean of 3.8 days.
Mean Time from CT Simulation to Palliative Radiation Start3 monthsMean time from CT simulation to start of PRT will be computed for our sample and compared to the historical control mean of 6.1 days.
Quality of Life Changes1 and 3 months after treatment completionLevels of and changes in patient-reported overall quality of life as measured by the EORTC QLQ-C15-PAL (14 questions) at baseline and at 1-month and 3-month intervals after end of palliative radiation therapy. Quality of life score scale consists of 1 = not at all to 4 = very much. The higher the QOL score the greater change in the participant's quality of life.
Overall Survival6 months after treatment completionMedian overall survival (number of days between start of radiation therapy and death from any cause) will be estimated using the Kaplan-Meier method and compared (with a one-sample logrank test and assuming a Weibull distribution parameter of 1.0) to the median overall survival of n=134 days in our historical control.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026